Antibiotics can be life-saving, but their overuse can lead to the evolution of antibiotic resistance. Resistance occurs when bacteria develop the ability to survive exposure to antibiotics, making them harder to treat.
One way to combat antibiotic resistance is to develop new antibiotics. However, this is a time-consuming and expensive process. Another approach is to find ways to block the evolution of resistance in the first place.
Interfering RNA (RNAi) is a mechanism by which gene expression can be regulated. RNAi molecules are short pieces of RNA that are complementary to specific sequences of mRNA. When an RNAi molecule binds to an mRNA molecule, it can prevent the mRNA from being translated into protein.
Researchers at ETH Zurich have shown that RNAi can block the evolution of antibiotic resistance in bacteria. They used RNAi to target genes that are involved in antibiotic resistance. When the researchers exposed bacteria to antibiotics in the presence of RNAi, the bacteria were unable to develop resistance.
This research suggests that RNAi could potentially be used to treat antibiotic resistance. However, more research is needed to determine whether RNAi can be effective in treating antibiotic resistance in humans.
In addition to blocking antibiotic resistance, RNAi could also be used to treat other bacterial infections. For example, RNAi could be used to target genes that are involved in the virulence of bacteria. This could make bacteria less likely to cause disease.
RNAi is a promising new technology with the potential to revolutionize the treatment of bacterial infections.
